These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10556663)

  • 21. The tyranny of the anecdote: Waldenstrom's macroglobulinemia and scleritis.
    Rosenbaum JT; Becker MD
    Ocul Immunol Inflamm; 2000 Jun; 8(2):111-3. PubMed ID: 10980683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-proteinuric renal al amyloidosis in waldenström's macroglobulinemia.
    Lesourd A; Francois A; Etienne I; Guerrot D
    Nephrology (Carlton); 2019 Apr; 24(4):490-491. PubMed ID: 30919534
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
    Mailankody S; Landgren O
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood viscosity in Waldenström's macroglobulinemia.
    Mannik M
    Blood; 1974 Jul; 44(1):87-98. PubMed ID: 4209572
    [No Abstract]   [Full Text] [Related]  

  • 25. A review of Waldenstrom's macroglobulinemia.
    McDermott MK; Bell EM
    Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous occurrence of IgM-lambda paraprotein with pyroprecipitation properties and cryoglobulin in the serum of a patient with Waldenström's macroglobulinemia.
    Tichý M; Hrncír Z; Mracek J
    Neoplasma; 1978; 25(6):741-4. PubMed ID: 109780
    [No Abstract]   [Full Text] [Related]  

  • 27. [Waldenström's macroglobulinemia with preserved antierythrocyte and antilipoprotein antibody activity].
    Zittoun R; Beaumont JL; Homberg JC; Carbonniere C; Debre P; Bousser J
    Sem Hop; 1975 Dec; 51(48):2943-8. PubMed ID: 175506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunofluorescence studies in Waldenström's macroglobulinemia.
    Preud'homme JL; Hurez D; Seligmann M
    Rev Eur Etud Clin Biol; 1970 Dec; 15(10):1127-31. PubMed ID: 4996339
    [No Abstract]   [Full Text] [Related]  

  • 29. Marked increase in serum IgM during treatment of Waldenstrom's macroglobulinemia with cladribine.
    Krishna VM; Carey RW; Bloch KJ
    N Engl J Med; 2003 May; 348(20):2045-6. PubMed ID: 12748329
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
    Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the aggregation of red cells in Waldenström's macroglobulinaemia and multiple myeloma.
    Dintenfass L; Somer T
    Microvasc Res; 1975 May; 9(3):279-86. PubMed ID: 805345
    [No Abstract]   [Full Text] [Related]  

  • 32. Electrophoresis of human multiple myeloma and Waldenström's macroglobulinemia sera in sodium dodecyl sulfate polyacrylamide gels.
    Hayes LC; Plapp FV; Brewer GJ; Rucker M; Moore D; Tilzer LL; Chiga M
    Clin Chim Acta; 1976 Jan; 66(1):119-23. PubMed ID: 816578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Monoclonal IgM interference with immunoturbidimetric determination of transferrin].
    Boniol C; Tournilhac O; Kuder P; Guyon M; Dastugue B; Motta C; Sapin V
    Ann Biol Clin (Paris); 2002; 60(4):481-4. PubMed ID: 12147455
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of bone marrow response in Waldenström's macroglobulinemia.
    Varghese AM; Rawstron AC; Ashcroft AJ; Moreton P; Owen RG
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):53-5. PubMed ID: 19362973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble CD27 is a faithful marker of disease burden and is unaffected by the rituximab-induced IgM flare, as well as by plasmapheresis, in patients with Waldenström's macroglobulinemia.
    Ciccarelli BT; Yang G; Hatjiharissi E; Ioakimidis L; Patterson CJ; Manning RJ; Xu L; Liu X; Tseng H; Gong P; Sun J; Zhou Y; Treon SP
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):56-8. PubMed ID: 19362974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low molecular weight IgM-immunoglobulins in Waldenström's macroglobulinemia.
    Dammacco F; Giustino V; Bonomo L
    Prog Immunobiol Stand; 1970; 4():205-8. PubMed ID: 4991583
    [No Abstract]   [Full Text] [Related]  

  • 38. Histidine based adsorbents for selective removal of monoclonal immunoglobulin IgM antibodies from Waldenstrom's macroglobulinemia patient sera: a preliminary study.
    Srour M; Kassab I; Matta H; Elkak A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():1-5. PubMed ID: 23811496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-reactive protein-immunoglobulin complexes in two patients with macroglobulinemia.
    Grützmeier S; von Schenck H
    Scand J Clin Lab Invest; 1987 Dec; 47(8):819-22. PubMed ID: 3124259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.